/
Page Corporate Overview 6 Business Strategy 7 Financial Strategy 9 Business Segments 9 Advanced Materials Segment 9 Additives & Functional Products Segment 11 Chemical Intermediates Segment 12 Fibers Segment 13 Eastman Chemical Company General Information 15 5 Tab le of Contents CORPORATE OVERVIEW Eastman Chemical Company ("Eastman" or the "Company") is a global specialty materials company that…
$68.60
$0.56 (-0.81%)
EOD Jul 17, 2026
10.64% operating margin is respectable but not wide. ROIC at 7.78%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 6.7% YoY. Margins deteriorated 3.3pp alongside, both lines moving the wrong way.
Free cash flow declined 38% versus the prior year, cash generation momentum has weakened. ROIC dropped from 10.75% to 7.78%, capital efficiency is deteriorating.
19.8x earnings, 15.8x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$8.64B
▼ -6.7% YoY
Net Income (TTM)
$399M
▼ -47.6% YoY
Op. Margin
9.33%
▼ -3.3pp YoY
ROIC
6.89%
▼ -3.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$498M
▼ -38.4% YoY
Op. Cash Flow (TTM)
$1.00B
▼ -24.6% YoY
Net Debt
$4.55B
Cash & Equiv.
$665M
5Y CAGR: +0.7%
5Y CAGR: -16.9%
Continue Research
At a P/E of 19.8 and a price-to-free-cash-flow of 15.8, Eastman Chemical (EMN) trades above a two-stage DCF intrinsic value of about $35.44 per share, so at $68.60 the stock looks overvalued (48.3% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Eastman Chemical scores 46/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 4.8%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $35.44 per share for EMN, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $26.58. At today's $68.60, that puts the stock about 48.3% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Eastman Chemical scores 46 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 9.3% operating margin and a 6.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Eastman Chemical pays a regular dividend of about $3.31 per share per year (typically in quarterly installments), a yield of roughly 4.8% at the current price. That is a payout ratio of about 95.5% of earnings, so the dividend is stretched at this level. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For EMN's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. EMN currently trades above its estimated intrinsic value and scores 46/100 on quality (mixed). It also yields about 4.8%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.